of Clara cells decreases, and if the bond of the CC with the epithelial layer is weakly expressed upon cooling, Clark cells are in contact with the epithelium under the action of DKV. DKV has a normalizing effect on LPO reactions. In lung tissue, this results in a 16% decrease in diene conjugate values, hydroperoxides by 10% and vitamin E growth by 15%. In peripheral blood, hydropericidia are significantly reduced by 20%, MDA by 40%, vitamin E increases by 13% and ceruloplasmin by 15%.
Topicality. Burns therapy presents a global, social and economic problem in combustiology and surgery. It is known that among victims patients with superficial and border-line burns prevail making up 80% [1] . Such injuries do not lead to the development of a burn disease, they need the effective conservative treatment which can stimulate regenerative processes in a zone of the burn. According to modern literature hyperbaric oxygenation stirs up phagocytic activity of cells reparation and rate of their passing into the wound, stimulates action of antibacterial therapy [2] . Besides, in pathogenesis of a process developing in the wound great attention is paid to the active part of uncontrolled formation of free radicals in cells which further deceleration of reparation processes [3] . Application of antioxidants is pathogenetically substantiated. Because dihydroquercetin is a strong exogenous antioxidant having capillary protective, anti-inflammatory and moisture keeping effects then the probability of influence on the processes of LPO (lipid peroxidation) is high that intensifies the fibroblast reaction [4] .
Objective: to assess the results of a complex application of hyperbaric oxygenation and dihydroquercetin ("Lavitol cosmetic", BAA "Lavitol-B") in the treatment of patients with superficial burns. Materials and methods: the analysis of therapy results of 88 patients with burns of the I-II degrees (MKB-10) was conducted. Among them there were 49 men (55,7%) and 39 women (44,3%) at the age of 20-71 years. Etiology of thermal injuries: scalds -in 50 (56,8%), flame burns -in 25 (28,4%), contact burns -in 11 (12,5%), scalds -in 2 (2,3%) cases. Burn shock of the I-II degrees was observed in 6 patients with a burn area of 15% and 18%. A burn disease was developing from 14 days till 2 months. On the average the area of thermal injuries made up 630,8 ± 6,7 cm 2 .
The main group (MG) included 44 patients receiving HBO and antioxidant therapy with bioflavonoid dihydroquercetin ("Lavitol cosmetic", BAA "Lavitol -B"). Therapy methods of patients of the main group were the following: after thorough cleansing of a burning wound, removing exfoliated epidermis and treatment with antiseptic (0,5% solution of chlorhexidine bigluconate) dressings with the powder of dihydroquercetin "Lavitol cosmetic" were performed in a day during 10-20 days. It was applied to the wound with the presence of microbes not more than 103-4 b.m. per 1 cm2 in the layer of 1-2 mm. Atraumatic covering "Parapran" was applied over. At the same time hyperbaric oxygenation of 1,5-1,8 atmospheres during 40 minutes was conducted daily for 10 days. Besides, peroral intake of biologically active additive "Lavitol -B" was administered (1 capsule twice a day during meals daily for 15 days). Biologically active additive "Lavitol -B" contains natural antioxidant dihydroquercetin and polysaccharide arabinogalactan (1:3). Patients of the main group and the control group are similar in sex, age, degree and burns area.
Complex of therapy methods for patients from both groups included antibacterial and symptomatic treatment.
The results were analyzed according to indices of developing a burning disease, cytological examination, lipid peroxidation study and antioxidant defense (vitamin "E", ceruloplasmin), pro-inflammatory interleukins (IL-1β, IL-6, IL-8, TNF-α),) on the first and 10-th day of therapy. The degree of differences was considered to be significant when p < 0,05.
Results: Due to more active processes developing in the wound earlier terms of forming marginal (7,6 ± 1,6 days) and complete epithelization of wounds (28,2 ± 3,3 days), scarring (31,3 ± 2,4 days) (p < 0,05) were determined for certain in patients of the main group in comparison with patients of the control group (10,7 ± 1,4 days, 20,9 ± 3,8 days, 29,9 ± 2,3 days, 39,7 ± 3,2 days accordingly). Duration of the temperature reaction is 11,9 ± 0,6 days and that of the painful syndrome in the main group made up 13,4 ± 0,7 days. These indices in the control group made up 16,6 ± 0,7 days and 19,9 ± 1,5 days accordingly (p < 0,05).
Cellular composition of the wounds on the first day of therapy did not significantly differ in patients of both groups. In the 21-st day of therapy regenerative and regenerative -inflammatory types of cytograms were determined in patients of the main group while inflammatory and regenerative type of cytograms remained in patients of the control group.
Patients with superficial burns in both groups had excessive and lingering hyperproduction of pro-inflammatory interleukins (IL-1β, IL-6, IL-8, TNF-α). Application of the proposed method furthered the decrease of their level and acceleration of reparation processes. By the 10-th day of therapy in patients of the main group having burning wounds the level of IL-1β content in the serum decreased by 45 At the beginning of therapy there were not significant differences in indices of lipid peroxidation and AOD in patients of both groups. M.u. indices decreased by 46,8% and r.c. indices -by 47,9% in patients of the main group by the tenth day of treatment while m.u. indices decreased by 20,4% and r.c. indices -by 31,7% in patients of the control group. The content of AOD components increased significantly in the main group than in the control one. In patients of the main group the content of vitamin "E" increased by 39,1% and that of ceruloplasmin -by 35,4% and in the control group -by 8,7% and -by 3,6% accordingly.
Conclusion. Application of HBO and antioxidant therapy with dihydroquercetin (Lavitol cosmetic", BAA "Lavitol -B").) activates the process developing in the wound that allows to improve the results of treatment of patients with superficial burns.
